Natalizumab

Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer trea&tradeent. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in

Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer trea&tradeent. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in

Obinutuzumab is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer trea&tradeent. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in

General description Anti-OLFML2B Antibody detects endogenous levels of total OLFML2B protein. Immunogen The antiserum was produced against synthesized peptide derived from human OLFML2B.

Panitumumab with trade name Vectibix, is an FDA-approved drug for the treatment of patients with EGFR-expressing metastatic colorectal carcinoma with non-mutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin- and

Panitumumab with trade name Vectibix, is an FDA-approved drug for the treatment of patients with EGFR-expressing metastatic colorectal carcinoma with non-mutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin- and

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S.

ANTI-PLACENTAL LACTOGEN CLONE MAB-12

ANTI-PLACENTAL LACTOGEN CLONE MAB-12

ANTI-POLQ CLONE 2F5 ZOOMAB« RABBIT MONOCLONAL

ANTI-POLQ CLONE 2F5 ZOOMAB« RABBIT MONOCLONAL

General description Ras-related protein Rab-7A (Rab7A, RAB7) is a small intracellular protein typically associated with cytoplasmic vesicles, phagosomes, and endosomes and is expressed in most cells but particularly high in muscle. It plays an